A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc.
Incyte Corporation
DEKA Biosciences
Celldex Therapeutics
Myeloid Therapeutics
GlaxoSmithKline
AVAX Technologies
Bristol-Myers Squibb
Pfizer
FeRx